Deals in healthcare M&A have soared over the past two years, continuing to attract capital and drive activity in the sector. Industry insiders are monitoring the current pace of healthcare M&A deals and developing an outlook for 2008. This one-day symposium in March will bring together strategic acquirers, private equity and other alternative investors to acquire the foremost dealmakers’ outlook on mergers and acquisitions taking place in the healthcare industry, top deals and the transactions impacting healthcare M&A. Leading investors will discuss what key deal trends and opportunities to expect in pharmaceuticals, biotech, drug discovery, medical devices, healthcare services and technology sectors in the next 12 months.
Who Should Attend?
The Healthcare Dealmaking Symposium is a must for all dealmakers in the healthcare sector including:
• Corporate development executives
• Hedge Fund managers
• Private Equity groups
• Venture Investors
• Investment Bankers
• Intermediary professionals
• Professional Service providers
For more information about sponsorship and exhibitor opportunities,